1-6 of 6
Authors: Maria J Perez-Elias
Journal Article
Factors associated with the number of drugs in darunavir/cobicistat regimens Free
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 1, January 2020, Pages 208–214, https://doi.org/10.1093/jac/dkz399
Published: 05 October 2019
Journal Article
Virological failure to raltegravir in Spain: incidence, prevalence and clinical consequences Free
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 11, November 2015, Pages 3087–3095, https://doi.org/10.1093/jac/dkv205
Published: 30 July 2015
Journal Article
Efficacy of dual therapy with lamivudine plus darunavir boosted with ritonavir once daily in HIV-infected patients with nucleoside analogue toxicity Get access
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 2, February 2015, Pages 630–632, https://doi.org/10.1093/jac/dku402
Published: 09 October 2014
Journal Article
Virological response to short-course maraviroc monotherapy does not predict viral tropism in HIV-1-infected treatment-naive patients Get access
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 7, July 2014, Pages 1916–1919, https://doi.org/10.1093/jac/dku059
Published: 12 March 2014
Journal Article
Raltegravir pharmacokinetics in HIV/HCV-coinfected patients with advanced liver cirrhosis (Child-Pugh C) Get access
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 2, February 2014, Pages 471–475, https://doi.org/10.1093/jac/dkt386
Published: 04 October 2013
Journal Article
Resistance to the most recent protease and non-nucleoside reverse transcriptase inhibitors across HIV-1 non-B subtypes Get access
Journal of Antimicrobial Chemotherapy, Volume 68, Issue 9, September 2013, Pages 1994–2002, https://doi.org/10.1093/jac/dkt146
Published: 29 April 2013
